The largest database of trusted experimental protocols

W3500

Manufactured by Merck Group

The W3500 is a laboratory centrifuge designed for separating and concentrating samples. It features a compact and durable construction with a maximum speed of 3,500 RPM and a maximum RCF (Relative Centrifugal Force) of 1,697 x g. The W3500 is suitable for a variety of applications in research and clinical laboratories.

Automatically generated - may contain errors

6 protocols using w3500

1

Production and Infection of Lentiviral Particles

Check if the same lab product or an alternative is used in the 5 most similar protocols
For lentiviral particle production, 7.5 million low passage 293T/17 cells were seeded in 15 cm plates, incubated overnight and 2 h before transfection media was replaced. For each plate, 44 µg of pLKO.1-shRNA (Sigma), 13 µg of VSV-G envelope and 33 µg of delta 8.9 packaging vectors were mixed with 1125 µL of endotoxin-free water (Sigma, W-3500) and 125 µL of 2.5 M CaCl2 (Sigma). After incubating the mix for 5 min in a rotor, 1250 µL of 2× HBS pH 7.2 (281 mM NaCl, 100 mM HEPES, 1.5 mM Na2HPO4) were added in a drop-wise manner. After 10min of incubation at room termperature, the precipitate was added dropwise to the cells and incubated for 30 h. Virus-containing supernatants were collected, filtered (0.22 µm) and centrifuged at 20,000rpm at 4°C for 2 h in a SW32Ti rotor (Beckman). Lentiviral pellets were resuspended in 80 µL of PBS and kept at −80°C.
For lentiviral infections, cells were incubated with concentrated lentivirus overnight and subcultured with fresh medium the following day. Forty-eight hours after infection, cells were selected with puromycin (1 µg/mL for U2OS, 2 µg/mL for HeLa) for 2 d.
+ Open protocol
+ Expand
2

Peptide-based Hydrogel Fabrication

Check if the same lab product or an alternative is used in the 5 most similar protocols
A commercially available peptide preparation in powder form was used as the source of the octapeptide gelator (FEFEFKFK, Phe-Glu-Phe-Glu-Phe-Lys-Phe-Lys). As part of this study we used peptide sourced from Cambridge Research Biochemicals (batch 32597) although we also verified the fabrication method using a second peptide source (Pepceuticals, UK). To form each precursor, a mass of between 7.5 and 18.75 mg peptide preparation was dissolved in 800 μL sterile water (W3500 Sigma), using a 3 min vortex step followed by centrifugation (3 min at 1000 rpm) and a 2 h incubation at 80 °C. After incubation, 0.5 M NaOH (S2770 Sigma) was added incrementally to the gels until optically clear. Gels were vortexed, buffered by addition of 100 μL 10× PBS (70011 Gibco), and incubated at 80 °C overnight. The resulting precursors could be stored at 4 °C until required.
+ Open protocol
+ Expand
3

Cultivation of Treponema pallidum

Check if the same lab product or an alternative is used in the 5 most similar protocols
TpCM-2 was prepared as indicated in Table 4 1 day prior to use. All solutions were made in cell culture-grade water (Sigma W3500) and filter sterilized. Fetal bovine serum (FBS) lots vary considerably in their ability to support T. pallidum survival and replication (16 (link), 38 (link), 51 (link)). FBS lots from several suppliers were therefore prescreened for efficacy (by comparison with previously tested lots), purchased in bulk, and heat inactivated at 56°C for 30 min prior to use. Samples of FBS lots that support the multiplication of T. pallidum are available upon request. The pH of the medium was adjusted to 7.5, and the mixture was then filter sterilized with 0.22-µm-pore-size polyethersulfone filters (Merck Millipore). The medium was then preequilibrated in a BBL GasPak jar in which a vacuum was drawn five times (house vacuum; ~12 to 18 µm Hg), and the jar was refilled with 5% CO2–95% N2 four times and a final time with 1.5% O2–5% CO2–93.5% N2. The medium was then incubated overnight in a Forma model 3130 trigas incubator (Thermo Fisher) maintained at 34°C with 1.5% O2–5% CO2–93.5% N2 (here referred to as the low-oxygen incubator). All subsequent steps in the incubation of T. pallidum cultures were carried out under these conditions.
+ Open protocol
+ Expand
4

Hydrogel Precursor Synthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The precursor and gel preparation method was followed as previously published57 . A commercially available peptide preparation in powder form was used as the source of the octapeptide gelator (Pepceuticals UK, FEFEFKFK, Phe-Glu-Phe-Glu-Phe-Lys-Phe-Lys). To form the precursor, a mass of 10 mg peptide preparation was dissolved in 800 μL sterile water (Sigma, W3500), using a 3 min vortex step followed by centrifugation (3 min at 1000 rpm) and a 2 h incubation at 80 °C. After incubation, 0.5 M NaOH (Sigma, S2770) was added incrementally to the gel until optically clear. The gel was vortexed, buffered by addition of 100 μL 10× PBS (Gibco, 70011), and incubated at 80 °C overnight. The resulting precursor could be stored at 4 °C until required.
+ Open protocol
+ Expand
5

Neurotransmitter Receptor Agonist Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATP (disodium salt), -meATP (lithium salt), adenosine deaminase (ADA), carbamylcholine chloride (Carbachol), collagenase (Type 1A), sodium nitroprusside, TEA (chloride salt) and TTX were obtained from Sigma-Aldrich (Gillingham, UK). Sterile water (W3500; Sigma Aldrich) was used in the luciferase assay. MRS2179 was obtained from Tocris-Cookson Ltd (Bristol, UK) and A-317491 was a gift from Abbvie Inc. (Illinois, USA).
Conotoxin GVIA was a gift from Professor Annette Dolphin (NPP, UCL). All drugs were made up in de-ionised, filtered and sterile water as stocks of either 10 mM or 100 mM, and stored at -20°C. Drugs were thawed just before use and diluted in a modified Krebs solution or Ringer's solution.
+ Open protocol
+ Expand
6

Octapeptide Hydrogel Precursor Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The precursor and gel preparation method was followed as previously published 57 (link) . A commercially available peptide preparation in powder form was used as the source of the octapeptide gelator (Pepceuticals UK, FEFEFKFK, Phe-Glu-Phe-Glu-Phe-Lys-Phe-Lys). To form the precursor, a mass of 10 mg peptide preparation was dissolved in 800 μL sterile water (Sigma, W3500), using a 3 min vortex step followed by centrifugation (3 min at 1000 rpm) and a 2 hour incubation at 80 °C. After incubation, 0.5 M NaOH (Sigma, S2770) was added incrementally to the gel until optically clear. The gel was vortexed, buffered by addition of 100 μL 10x PBS (Gibco, 70011), and incubated at 80 °C overnight. The resulting precursor could be stored at 4 °C until required.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!